Skip to content
Screener

Reported August 13, 2026 · Before market open

EPS-$0.62Miss by $0.02
EPS estimate-$0.60

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.6M
EPS estimate-$0.35

FAQ

When did MiNK Therapeutics, Inc. report Q2 2026 earnings?
MiNK Therapeutics, Inc. (INKT) reported Q2 2026 earnings on August 13, 2026 before market open.
What were MiNK Therapeutics, Inc.'s Q2 2026 revenue and EPS?
MiNK Therapeutics, Inc. reported eps of $-0.62 for Q2 2026.
Did MiNK Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.60 by $0.02.
How did MiNK Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 41.5% from $-1.06.
Where can I find MiNK Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-347907) and the 10-Q periodic report (0001193125-26-349309) directly on SEC EDGAR. The filing index links above go to sec.gov.